证券代码：688272 证券简称：*ST 富吉 公告编号：2023-051 北京富吉瑞光电科技股份有限公司 首次公开发行部分限售股上市流通公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 一、本次上市流通的限售股类型 根据中国证券监督管理委员会于 2021 年 8 月 31 日出具的《关于同意北京富 吉瑞光电科技股份有限公司首次公开发行股票注册的批复》（证监许可[2021] 2820 号），北京富吉瑞光电科技股份有限公司（以下简称"公司"或"富吉瑞"） 获准向社会公开发行人民币普通股 19,000,000 股，并于 2021 年 10 月 18 日在上 海证券交易所科创板上市交易。公司首次公开发行前总股本为 57,000,000 股， 发行后总股本为 76,000,000 股，其中有限售条件流通股 60,541,969 股，无限售 条件流通股 15,458,031 股。公司首次公开发行的网下配售股合计 691,969 股已 于 2022 年 4 月 18 日上市流通。 本次上市流通的限售股为公司首次公开 ...

关于北京富吉瑞光电科技股份有限公司 首次公开发行部分限售股解禁上市流通的核查意见 华英证券有限责任公司（以下简称"华英证券"、"保荐机构"）作为北京富 吉瑞光电科技股份有限公司（以下简称"富吉瑞"、"上市公司"、"公司"） 首次公开发行 A 股股票的持续督导保荐机构，根据《证券发行上市保荐业务管 理办法》《上海证券交易所科创板股票上市规则》《上海证券交易所上市公司自律 监管指引第 11 号——持续督导》等有关法律法规规定，对富吉瑞首次公开发行 股票部分限售股解禁上市流通事项进行了认真、审慎的核查，发表核查意见如下： 一、本次上市流通的限售股类型 华英证券有限责任公司 根据中国证券监督管理委员会于 2021 年 8 月 31 日出具的《关于同意北京富 吉瑞光电科技股份有限公司首次公开发行股票注册的批复》（证监许可 [2021]2820 号），公司获准向社会公开发行人民币普通股 19,000,000 股，并于 2021 年 10 月 18 日在上海证券交易所科创板上市交易。公司首次公开发行前总股本为 57,000,000 股，发行后总股本为 76,000,000 股，其中有限售条件流通股 60,541,969 股 ...

Financial Performance - The company's gross profit margin for the main business decreased from 35.40% in the first half of 2022 to 26.04% in the first half of 2023[4]. - The company's operating revenue for the first half of 2023 reached ¥90,153,126.39, representing a 223.76% increase compared to ¥27,845,427.09 in the same period last year[21]. - The net profit attributable to shareholders was -¥46,949,680.65, slightly worsening from -¥43,244,717.68 year-on-year[21]. - The net cash flow from operating activities improved significantly to ¥27,961,608.88, compared to -¥54,638,214.87 in the previous year[21]. - The company's total assets decreased by 10.39% to ¥671,112,419.19 from ¥748,961,427.23 at the end of the previous year[22]. - The net assets attributable to shareholders decreased by 7.77% to ¥538,462,895.95 from ¥583,803,259.10 at the end of the previous year[22]. - The basic earnings per share for the first half of 2023 was -¥0.62, compared to -¥0.57 in the same period last year[23]. - The company reported a total revenue of 8,702 million CNY for the first half of 2023, with a net profit of 3,418 million CNY, representing a profit margin of approximately 39.2%[57]. - The company reported a net loss of ¥28,100,052.09, a 249.07% decline compared to the previous period[97]. - The company reported a total of 3,021,403 shares held by Hu Lan, with a price of 3.98 RMB per share[170]. Risks and Challenges - The company faces delisting risk due to a negative net profit attributable to shareholders and revenue below RMB 100 million in 2022[4]. - The report highlights various risks faced by the company, including declining gross margins and potential bad debts from accounts receivable[4]. - The company faces a risk of product price decline due to intense market competition, which could adversely affect future profitability if operational strategies are not adjusted accordingly[80]. - The company is at risk of delisting due to a negative net profit and revenue below CNY 100 million in 2022, which could trigger delisting procedures if similar conditions persist in 2023[80]. - The company relies on external procurement for core components like detectors, which can increase costs by approximately 20-35%, impacting price competitiveness[84]. - The company is facing quality control risks as it scales operations, necessitating continuous improvement in its quality management systems[86]. Research and Development - The research and development expenditure accounted for 37.92% of operating revenue, a decrease of 64.29 percentage points from 102.20% in the previous year[23]. - The company has developed multiple core technologies in the infrared thermal imaging field, achieving domestic advanced or near-international advanced levels in key products such as handheld thermal imagers and optical radar systems[35]. - The company has established a robust R&D system, enhancing core competitiveness from the design of components to the development of comprehensive optoelectronic systems[44]. - The company has accumulated rich industry experience and technical reserves, with core technologies including multi-point temperature imaging compensation and low-power large-area sensor driving technology[45]. - The company has developed a non-contact temperature measurement technology that significantly improves the efficiency and accuracy of industrial equipment temperature detection[46]. - The company has a strong R&D team with 138 personnel, representing 47.59% of total employees, and has established a comprehensive R&D organizational structure[71]. - Research and development expenses increased by 20.12% year-on-year, totaling approximately ¥34.18 million, attributed to the ongoing implementation of fundraising projects and increased related R&D expenditures[52][53]. - The company has completed the design and development of two non-cooled infrared detectors, 640×512 and 1280×1024, with a pixel size of 12μm[68]. Corporate Governance - There are no special arrangements for corporate governance or non-operating fund occupation by controlling shareholders[8]. - The report is unaudited, and the management has confirmed the accuracy and completeness of the financial statements[6]. - The company has not proposed any profit distribution or capital reserve transfer to increase share capital during this reporting period[7]. - The company held a shareholders' meeting on May 26, 2023, where all proposals were approved[101]. - The company has not reported any administrative penalties due to environmental issues during the reporting period[109]. Environmental Responsibility - The company actively implements environmental protection measures and has established a comprehensive environmental management system[112]. - Wastewater generated by the company meets the Beijing water pollution discharge standards[112]. - Solid waste is classified and collected, with regular disposal by local sanitation agencies[113]. - The company has adopted energy-saving equipment to reduce electricity consumption and greenhouse gas emissions[114]. Future Outlook - The company is committed to addressing the challenges posed by increased competition in the industry[4]. - Future outlook includes a focus on product structure and cost control to mitigate risks associated with gross margin decline[4]. - The company plans to invest in new product development and market expansion strategies in the upcoming quarters[162]. - The overall R&D strategy focuses on enhancing product competitiveness and expanding market applications in both military and civilian sectors[57]. Shareholder Information - The company has a total of 2,841 common stock shareholders as of the end of the reporting period[167]. - The top shareholder, Ningbo Ruijifu Technology Center, holds 14,672,272 shares, accounting for 19.31% of total shares[169]. - The company has not reported any changes in the controlling shareholder or actual controller during the reporting period[174]. - The company has not experienced any changes in its share capital structure during the reporting period[165].

经核查，公司 2023 年半年度的募集资金存放和使用符合《上市公司监管指 引第 2 号——上市公司募集资金管理和使用的监管要求》《上海证券交易所科创 板上市公司自律监管指引第 1 号——规范运作》及公司《募集资金管理制度》的 规定，对募集资金进行了专项存储，不存在变相改变募集资金用途和损害股东利 益的情况，不存在违规使用募集资金的情形。《2023 年半年度募集资金存放与使 用情况的专项报告》如实反映了公司 2023 年半年度募集资金存放和使用的实际 情况。 综上，我们同意公司第二届董事会第二次会议审议的《关于<2023 年半年度 募集资金存放与使用情况的专项报告>的议案》。 北京富吉瑞光电科技股份有限公司 独立董事关于第二届董事会第二次会议 相关事项的独立意见 根据《上市公司独立董事规则》《上市公司治理准则》《上海证券交易所科创 板股票上市规则》等相关法律、法规及规范性文件及《公司章程》《独立董事工 作制度》等的规定，我们作为公司的独立董事，本着认真、负责的态度和独立判 断的原则，对公司第二届董事会第二次会议审议的相关议案，发表如下独立意见： 一、关于《2023 年半年度募集资金存放与使用情况的专项报告》的独 ...

证券代码：688272 证券简称：*ST 富吉 公告编号：2023-047 北京富吉瑞光电科技股份有限公司 关于注销武汉分公司的公告 注册地址：湖北省武汉市东湖新技术开发区关东街道茅店村博瀚科技光电子 信息产业基地二期 2 栋 B 单元 3 层 1 号房-8 负责人：李宜斌 成立日期：2022-08-16 营业期限：2022-08-16 至 无固定期限 经营范围：一般项目：电子产品销售；智能仪器仪表制造；电气信号设备装 置制造；电子专用设备制造；集成电路设计；人工智能应用软件开发；技术服务、 技术开发、技术咨询、技术交流、技术转让、技术推广（除许可业务外,可自主 依法经营法律法规非禁止或限制的项目） 二、董事会会议审议情况 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 根据北京富吉瑞光电科技股份有限公司（以下简称"公司"）整体经营规划， 为优化企业组织架构，提高公司管理效率，公司拟注销北京富吉瑞光电科技股份 有限公司武汉分公司，并授权公司经营管理层办理本次分公司注销相关事宜。具 体情况如下： 一、拟注销分公司的基本情况 ...

证券代码：688272 证券简称：*ST 富吉 公告编号：2023-045 北京富吉瑞光电科技股份有限公司 第二届监事会第二次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 表决结果：同意 3 票，反对 0 票，弃权 0 票；本议案获得通过。 2、审议通过《关于<2023 年半年度募集资金存放与使用情况的专项报告> 的议案》 监事会认为：公司 2023 年半年度募集资金存放与实际使用情况符合《上市 公司监管指引第 2 号——上市公司募集资金管理和使用的监管要求》《上海证 券交易所科创板上市公司自律监管规则适用指引第 1 号——规范运作》等相关 法律法规的要求，公司对募集资金进行了专户存储，不存在变相改变募集资金 用途的情形，不存在损害股东利益的情形，也不存在募集资金使用违反相关法 律法规的情形。 一、监事会会议召开情况 北京富吉瑞光电科技股份有限公司（以下简称"公司"）第二届监事会第 二次会议于 2023 年 8 月 24 日在公司会议室以现场结合通讯的方式召开，公司 于 2023 年 8 月 14 日以邮件 ...

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 北京富吉瑞光电科技股份有限公司（以下简称"富吉瑞"或"公司"）于 2023 年 8 月 24 日召开第二届董事会第二次会议及第二届监事会第二次会议，会 议审议通过了《关于公司 2023 年半年度计提资产及信用减值准备的议案》，该 议案无需提交股东大会审议，现将具体情况公告如下： 一、计提减值准备情况概述 根据《企业会计准则》及公司制度的相关规定，为了真实、准确地反映公 司 2023 年半年度的财务状况和经营成果，基于谨慎性原则，公司对截至 2023 年 6 月 30 日合并报表范围内可能发生资产及信用减值损失的有关资产及信用计 提资产减值准备。 2023 年半年度，公司计提资产减值损失 1,638.54 万元，计提信用减值损失- 1,159.27 万元，具体如下表： 单位：万元 证券代码：688272 证券简称：*ST 富吉 公告编号：2023-048 北京富吉瑞光电科技股份有限公司 关于 2023 年半年度计提资产及信用减值准备的公告 二、计提减值准备事项的具体说明 （一） ...

证券代码：688272 证券简称：*ST 富吉 公告编号：2023-046 北京富吉瑞光电科技股份有限公司 关于 2023 年半年度募集资金存放与使用情况的专项报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、募集资金基本情况 （一）实际募集资金金额和资金到账时间 经中国证券监督管理委员会《关于同意北京富吉瑞光电科技股份有限公司首 次公开发行股票注册的批复》（证监许可[2021]2820 号）核准，北京富吉瑞光 电科技股份有限公司（以下简称"富吉瑞"或"公司"）于 2021 年 10 月 18 日 向社会首次公开发行人民币普通股（A 股）1,900 万股，每股发行价为 22.56 元， 募集资金总额为人民币 428,640,000.00 元，根据有关规定扣除发行费用 58,801,633.67 元后，实际募集资金金额为 369,838,366.33 元。该募集资金已 于 2021 年 10 月 13 日全部到账。容诚会计师事务所（特殊普通合伙）对公司本 次公开发行新股的资金到位情况进行了审验，并于 2021 年 1 ...

证券代码：688272 证券简称：*ST 富吉 公告编号：2023-050 北京富吉瑞光电科技股份有限公司 关于召开 2023 年半年度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 会议召开时间：2023 年 9 月 1 日(星期五) 下午 16:00-17:00 会议召开地点：上海证券交易所上证路演中心（网址：https://roads how.sseinfo.com/） 会议召开方式：上证路演中心网络互动 投资者可于 2023 年 8 月 25 日(星期五) 至 8 月 31 日(星期四)16:00 前 登录上证路演中心网站首页点击"提问预征集"栏目或通过公司邮箱 fujirui@ fjroe.com 进行提问。公司将在说明会上对投资者普遍关注的问题进行回答。 北京富吉瑞光电科技股份有限公司（以下简称"公司"）已于 2023 年 8 月 25 日发布公司 2023 年半年度报告，为便于广大投资者更全面深入地了解公司 2023 年半年度经营成果、财务状况，公司计划于 2023 年 9 月 ...

Financial Performance - In 2022, the company's operating revenue decreased significantly from 144.0681 million yuan to 110.8911 million yuan, with a net profit attributable to shareholders of the parent company at -87.6414 million yuan[4]. - The company's net profit after deducting non-recurring gains and losses also showed a loss, indicating a challenging financial year due to slow order signing and delivery progress[4]. - The company is at risk of delisting as its audited net profit was negative and operating revenue fell below 100 million yuan, which violates the Shanghai Stock Exchange's listing rules[4]. - The proposed profit distribution plan for 2022 is to not distribute profits or increase capital reserves due to the financial losses incurred[6]. - The company's operating revenue for 2022 was ¥110,891,094.70, a decrease of 65.12% compared to ¥317,927,242.89 in 2021[21]. - The net profit attributable to shareholders was -¥87,641,440.52, representing a decline of 214.65% from ¥76,443,601.71 in the previous year[21]. - The net profit after deducting non-recurring gains and losses was -¥93,194,847.19, down 241.19% from ¥66,005,689.75 in 2021[21]. - The company's total assets decreased by 5.82% to ¥748,961,427.23 from ¥795,255,000.45 in 2021[21]. - The basic earnings per share for 2022 was -¥1.15, a drop of 190.55% from ¥1.27 in 2021[22]. - The weighted average return on net assets was -13.90%, a decrease of 36.91 percentage points from 23.01% in 2021[22]. - The decline in revenue was attributed to economic downturns and delays in military procurement plans, leading to reduced order demand[23]. - The net cash flow from operating activities was -¥97,385,180.55, compared to -¥86,239,617.32 in 2021[21]. - The gross profit margin dropped from 52.69% in 2021 to 31.90% in 2022, indicating increased cost pressures and market competition[129]. - The company reported a significant decrease in financing cash flow, down 96.00% to 14,273,581.46 RMB, primarily due to last year's fundraising activities[156]. Research and Development - Research and development expenses accounted for 43.68% of operating revenue, an increase of 31.59 percentage points from 12.09% in 2021[22]. - The company increased R&D investments to explore new product markets and actively participated in military project bidding, resulting in higher expenses[23]. - R&D expenses amounted to 48.43 million yuan, accounting for 43.68% of operating revenue, with a year-on-year increase of 25.99%[34]. - The company added 8 new patents and 1 new software copyright in 2022, bringing the total to 70 effective authorized patents[34]. - The company has developed core technologies for the infrared panoramic radar, including the high-precision rotating platform and intelligent alarm technology[50]. - The company has developed multiple core technologies in the field of infrared thermal imaging, achieving key performance indicators that are at or near international advanced levels[70]. - The company has developed a new generation of vehicle auxiliary driving night vision imaging technology, integrating uncooled infrared thermal imaging sensors and low-light solid-state micro-light sensors for multi-spectral imaging capabilities[80]. - The company has filed for 20 new patents during the reporting period, including 5 invention patents and 8 utility model patents[83]. - The company is focusing on the development of advanced algorithms to improve image clarity and performance, addressing the increasing demands for automation in target detection and recognition[75]. Market and Competitive Position - The company aims to stabilize supply channels and reverse competitive trends in the context of declining prices for downstream products[32]. - The infrared thermal imaging industry is experiencing rapid growth, with increasing applications in both military and civilian sectors due to advancements in technology and decreasing costs[59]. - The company is positioned in a rapidly developing industry, with a significant reduction in reliance on imported products due to the rise of domestic infrared enterprises[60]. - The military market for infrared thermal imaging products is substantial, with high demand for reliability and performance, particularly in developed countries[60]. - The domestic civil infrared thermal imaging market is projected to reach $4.113 billion in 2023, with a compound annual growth rate (CAGR) of approximately 18.61% from 2020 to 2023[63]. - The company is actively expanding its presence in the civil market, focusing on applications in industrial temperature measurement, gas detection, and security monitoring[69]. - The company is committed to innovation through integrated technology, enhancing its product offerings in both military and civil sectors[69]. - The company is focused on expanding its market presence through new product development and technological advancements, targeting various applications including airborne, marine, and automotive sectors[93][94][96]. Governance and Compliance - The company has not engaged in any non-operating fund occupation by controlling shareholders or related parties, ensuring compliance with regulations[8]. - The company has not violated decision-making procedures for external guarantees, maintaining governance integrity[8]. - The financial report received a standard unqualified audit opinion from the accounting firm, indicating reliability in the financial statements[5]. - The company emphasizes the importance of rational investment and risk awareness in its forward-looking statements regarding future plans and strategies[7]. - The company has established an internal control system to enhance risk prevention capabilities and operational standards in accordance with national requirements[183]. - The company has complied with all relevant regulations regarding information disclosure, ensuring transparency and accuracy[177]. - There were no significant differences in corporate governance compared to the regulations set by the China Securities Regulatory Commission[178]. Operational Challenges - The company faces various operational risks, including a significant decline in performance and potential delisting risks, which investors should be particularly aware of[4]. - The company relies on external procurement for key components such as detectors and high-end lenses, which poses a supply chain risk[125]. - The company faces risks related to supplier relationships, particularly for critical components like detectors and lenses, which could impact production and costs[126]. - The company is actively working to optimize its talent management and recruitment strategies to mitigate risks associated with talent shortages as it expands[127]. - The company is focusing on integrating infrared and visible light sensors to improve the functionality of its handheld observation instruments[102]. Investment and Future Plans - The company aims to enhance its imaging technology by expanding into solid-state micro-light, short-wave, ultraviolet, and visible light areas over the next three to five years[168]. - The company plans to deepen its focus on military and professional markets to increase market share and brand awareness[170]. - The company intends to invest more resources in research and development to create products suitable for civilian and general markets, ensuring competitive advantages[170]. - The company will establish a professional R&D team and strengthen collaborations with academic and research institutions to improve R&D efficiency[170]. - The company plans to complete the development of an 8-10 km laser rangefinder, with a total investment of 350.00 million CNY and 170.09 million CNY invested so far[91].